These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 78950)

  • 1. An isotope-release assay and terminal-labeling assay for measuring cell-mediated allograft and tumor immunity to small numbers of adherent target cells.
    Tamerius JD; Garrigues HJ; Hellström I; Hellström KE
    J Immunol Methods; 1978; 22(1-2):1-22. PubMed ID: 78950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A microcytotoxicity assay using 51Cr for measuring specific cell-mediated and humoral immune responses.
    Della Penta D; Cipuzak PM; Phillips ME
    Int Arch Allergy Appl Immunol; 1979; 60(3):332-45. PubMed ID: 489137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity.
    Herberman RB; Nunn ME; Lavrin DH
    Int J Cancer; 1975 Aug; 16(2):216-29. PubMed ID: 50294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross virus-induced lymphoma.
    Glaser M; Herberman R
    J Natl Cancer Inst; 1976 Jun; 56(6):1211-5. PubMed ID: 62841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of adherent versus suspension target cells derived from adherent tissue culture lines to cell-mediated cytotoxicity in rapid 51Cr-release assays.
    Dorfman NA; Civin CI; Wunderlich JR
    J Immunol Methods; 1980; 32(2):127-39. PubMed ID: 7358991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes.
    Burton R; Thompson J; Warner NL
    J Immunol Methods; 1975; 8(1-2):133-49. PubMed ID: 807654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in vitro assay of cell-mediated cytotoxicity. Terminal labeling with 3h-leucine.
    Schechter B; Feldman M
    Transplantation; 1976 Oct; 22(4):337-44. PubMed ID: 62427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term 51chromium assay for in vitro cell-mediated tumor immunity. Correlation with simultaneously performed microplate assays.
    Steele G; Sjögren HO; Lannerstad O; Stadenberg I
    Int J Cancer; 1975 Oct; 16(4):682-93. PubMed ID: 1176212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro studies on cell-mediated cytotoxicity by means of a terminal labeling technique.
    More R; Yron I; Sasson SB; Weiss DW
    Cell Immunol; 1975 Feb; 15(2):382-91. PubMed ID: 122915
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of 51Cr release for detecting cell-mediated cytotoxic responses to solid chemically induced rat tumours.
    Zöller M; Price MR; Baldwin RW
    Br J Cancer; 1977 Jun; 35(6):834-43. PubMed ID: 194618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro induction of tumor-specific immunity. II. Activation of cytotoxic lymphocytes to murine oncofetal antigens.
    Chism SE; Burton RC; Warner NL
    J Natl Cancer Inst; 1976 Aug; 57(2):377-87. PubMed ID: 63560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated antitumor immune reactions under syngeneic conditions.
    Leclerc JC; Senik A; Gomard E; Plata F; Levy JP
    Transplant Proc; 1973 Dec; 5(4):1431-4. PubMed ID: 4359721
    [No Abstract]   [Full Text] [Related]  

  • 14. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro induction of cell-mediated immunity to murine leukemia cells. II. cytotoxic activity in vitro and tumor-neutralizing capacity in vivo of anti-leukemia cytotoxic lymphocytes generated in macrocultures.
    Kedar E; Schwartzbach M; Raanan Z; Hefetz S
    J Immunol Methods; 1977; 16(1):39-58. PubMed ID: 68086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
    Ting CC; Nunn ME; Park JY; Herberman RB
    J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
    Ting CC; Rodrigues D
    J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
    [No Abstract]   [Full Text] [Related]  

  • 18. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Equal sensitivity of normal or tumoral fibroblasts to cytotoxic and cytostatic effects of normal or "Corynebacterium parvum" activated peritoneal exudate cells (author's transl)].
    Fray A; Lorinet AM; Thobie N; Halpern B
    Ann Immunol (Paris); 1979; 130C(3):445-59. PubMed ID: 475346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.